ACX Therapeutics Analysis
What is ACX Therapeutics?
ACX Therapeutics develops synthetic compounds that mimic bacterial agents to combat microbes, targeting therapeutic applications in humans, animals, and crops.
Employees
2
Founded
2024
Investors
- Y Combinator
- TRIREC
- Mubadala Investment Company PJSC
YC Batch
S24
Product Features & Capabilities
- High specificity therapeutic compounds, advanced drug delivery systems, scalable and stable platform solution, targeted therapies for cancer and agriculture, environmentally friendly pest control measures.
Competitors Overview
ACX Therapeutics operates in the sustainable agriculture and animal health sectors, focusing on innovative drug delivery systems that provide eco-friendly alternatives to chemical pesticides. Its main competitors include:
- Benson Hill: This company leverages AI and CRISPR technology to optimi
Market Focus
ACX Therapeutics primarily focuses on the biotechnology industry, specifically in the development of therapeutic compounds that mimic the antimicrobial properties of bacteria for applications in humans, animals, and crops.
See something that needs updating? Suggest edits to this profile.